CD19 and systemic sclerosis: After gating leukocytes as CD45+ and lymphocytes on FSc and SSc, the markers CD3, CD19 in combination with TCRγδ and CD16+56 were used to define B-cells, TCRγδ+ or TCRγδ- T-cells and NK cells (Figure 1A).